To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational ...
St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC programmeThe patients received Lutetium (177Lu) rhPSMA-10.1 Injections at ...
Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...
It’s a problem with not nearly enough attention. Prostate cancer hits men hard all over the world—it’s one of the biggest ...
A few years ago, I had a patient who affectionately went by the name “Pops.” At 85 years young, he was full of life and juggling multiple health issues alongside prostate cancer, yet determined not to ...
Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...
Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...
What Is Akeega, and Why Does It Matter? Akeega is a dual-action tablet combining two medicines — niraparib and abiraterone acetate — that has been approved by the FDA in combination with prednisone (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback